We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Agronomics Limited | LSE:ANIC | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.80 | 7.80 | 7.90 | 7.90 | 7.75 | 7.80 | 1,117,258 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 30.88M | 22.37M | 0.0222 | 3.54 | 79.24M |
TIDMPEBI
RNS Number : 1834D
Port Erin Biopharma Investments Ltd
25 April 2017
25 April 2017
Port Erin Biopharma Investments Limited
("Port Erin" or "the Company")
Redemption of holding in the Magna Biopharma Income Fund
The Company announces that it will redeem for cash its entire holding of 87,125.729 units in the Magna Biopharma Income Fund ("MBIF"). Port Erin's holding in the MBIF was valued at GBP1,038,704 at 31 March 2017. This follows the decision by the Magna Umbrella Fund plc to close the MBIF. As a consequence, Port Erin will receive approximately GBP960,000 in cash which the Company intends to deploy in accordance with its stated policy to invest in the biopharma sector.
Enquiries
Port Erin Biopharma Northland Capital Partners Peterhouse Capital Investments Limited Limited Limited The Company Nomad and Broker Broker Denham Eke Matthew Johnson / David Lucy Williams (+44) (0) 1624 639396 Hignell (+44) (0) 207 (+44) (0) 203 861 6625 469 0936
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCDZLFLDZFXBBL
(END) Dow Jones Newswires
April 25, 2017 02:00 ET (06:00 GMT)
1 Year Agronomics Chart |
1 Month Agronomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions